KRSNAA NSE filing

Krsnaa Diagnostics Expands Himachal Pradesh CT Scan Facilities to 34 Institutions

The RealCase readMedium impact Positive

Krsnaa Diagnostics signed a PPP agreement with Himachal Pradesh health department to manage CT Scan facilities at 34 government institutions. This expands their services from 12 to 34 locations for an initial 7-year period, extendable by 3 years. The contract is largely cash-based.

Why it matters

The expansion to 34 facilities from 12 is a substantial increase in scope, which is likely to positively impact revenue and operational scale. However, the exact financial value is not yet estimated, hence the medium impact.

The market read

The company has secured a significant expansion of its services with a government entity, increasing the number of facilities under its management. This indicates business growth and a strengthened partnership.

Krsnaa Diagnostics Limited (KDL) has entered into a Public Private Partnership (PPP) Agreement with the Director Health Services, Health & Family Welfare Department, Government of Himachal Pradesh.

This agreement focuses on setting up, operating, managing, maintaining, and reporting of CT Scan Diagnostic Facilities at 34 Government Health Institutions across Himachal Pradesh. The project will be implemented on a PPP basis for an initial period of seven years, with a potential extension of three more years under mutually agreed terms. The services will largely be on a cash basis.

Previously, Krsnaa Diagnostics was managing CT Scan facilities at 12 government health institutions in the state. The scope has now significantly increased to 34 institutions, marking it as one of the largest government partnerships for the company in diagnostic services. This expansion reinforces Krsnaa Diagnostics' presence in Himachal Pradesh and its role as a key provider of diagnostic services.

The company has executed the agreement, and the broad consideration or size of this contract cannot be estimated as it is a new project.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under new orders. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing